News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
BIO Releases Statement Concerning Future…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on BIO's political contributions:   "As of today BIO will be pausing our political giving so we can…
BIO Statement on CMS' Approval of TennCare…
Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee…
BIO's Dr. Michelle McMurry-Heath Responds to …
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization, made the following comments in response to today's violence at the United States Capitol: "Today we watched in horror as angry and unruly mobs attacked…
Letters, Testimony, & Comments
BIO Comments on FDA’s Public Workshop on…
On Wednesday, December 23rd, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s October 2020 public workshop titled, “New Drugs Regulatory Program Modernization: Implementation of the Integrated Assessment of Marketing…
BIO Submits Comments on Final EPA PIP rule
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on proposed revisions to regulations related to the oversight of certain plant…
BIO Submits Testimony to Senate Hearing on Ag…
Innovative breakthroughs can secure our nation’s food supply by reducing greenhouse gas emissions throughout agricultural supply chains; strengthening producers’ resiliency to climate change while increasing production; and tackling hunger and…
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
Placeholder Image
January 12, 2021
In the wake of the violent riot at the U.S. Capitol last week, Biotechnology Innovation Organization (BIO) President and CEO Dr. Michelle McMurry-Heath condemned the attack and announced that all political donations by…
WuXi Global Forum
January 12, 2021
If there’s a silver lining to the past year, it’s that we’ve learned a lot about how to accelerate innovation and get breakthroughs to patients, even in the most trying times. On January 11, 2021, BIO President and CEO…
drugs
January 11, 2021
On December 29, 2020, a judge in the U.S. District Court for the Northern District of California issued an injunction that blocked the implementation of the “Most Favored Nation” drug reimbursement policy, which applies…